BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 24657879)

  • 1. Loss of MicroRNA-155 protects the heart from pathological cardiac hypertrophy.
    Seok HY; Chen J; Kataoka M; Huang ZP; Ding J; Yan J; Hu X; Wang DZ
    Circ Res; 2014 May; 114(10):1585-95. PubMed ID: 24657879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress.
    Huang ZP; Chen J; Seok HY; Zhang Z; Kataoka M; Hu X; Wang DZ
    Circ Res; 2013 Apr; 112(9):1234-43. PubMed ID: 23524588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts.
    Matkovich SJ; Wang W; Tu Y; Eschenbacher WH; Dorn LE; Condorelli G; Diwan A; Nerbonne JM; Dorn GW
    Circ Res; 2010 Jan; 106(1):166-75. PubMed ID: 19893015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-19a/b-3p protect the heart from hypertension-induced pathological cardiac hypertrophy through PDE5A.
    Liu K; Hao Q; Wei J; Li GH; Wu Y; Zhao YF
    J Hypertens; 2018 Sep; 36(9):1847-1857. PubMed ID: 29664809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy.
    Ucar A; Gupta SK; Fiedler J; Erikci E; Kardasinski M; Batkai S; Dangwal S; Kumarswamy R; Bang C; Holzmann A; Remke J; Caprio M; Jentzsch C; Engelhardt S; Geisendorf S; Glas C; Hofmann TG; Nessling M; Richter K; Schiffer M; Carrier L; Napp LC; Bauersachs J; Chowdhury K; Thum T
    Nat Commun; 2012; 3():1078. PubMed ID: 23011132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-206 Mediates YAP-Induced Cardiac Hypertrophy and Survival.
    Yang Y; Del Re DP; Nakano N; Sciarretta S; Zhai P; Park J; Sayed D; Shirakabe A; Matsushima S; Park Y; Tian B; Abdellatif M; Sadoshima J
    Circ Res; 2015 Oct; 117(10):891-904. PubMed ID: 26333362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy.
    Dong DL; Chen C; Huo R; Wang N; Li Z; Tu YJ; Hu JT; Chu X; Huang W; Yang BF
    Hypertension; 2010 Apr; 55(4):946-52. PubMed ID: 20177001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.
    Li Q; Xie J; Wang B; Li R; Bai J; Ding L; Gu R; Wang L; Xu B
    PLoS One; 2016; 11(2):e0148480. PubMed ID: 26914935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-27b-3p down-regulates FGF1 and aggravates pathological cardiac remodelling.
    Li G; Shao Y; Guo HC; Zhi Y; Qiao B; Ma K; Du J; Lai YQ; Li Y
    Cardiovasc Res; 2022 Jul; 118(9):2139-2151. PubMed ID: 34358309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-378 suppresses myocardial fibrosis through a paracrine mechanism at the early stage of cardiac hypertrophy following mechanical stress.
    Yuan J; Liu H; Gao W; Zhang L; Ye Y; Yuan L; Ding Z; Wu J; Kang L; Zhang X; Wang X; Zhang G; Gong H; Sun A; Yang X; Chen R; Cui Z; Ge J; Zou Y
    Theranostics; 2018; 8(9):2565-2582. PubMed ID: 29721099
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of MicroRNA-146a and Overexpression of Its Target Dihydrolipoyl Succinyltransferase Protect Against Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction.
    Heggermont WA; Papageorgiou AP; Quaegebeur A; Deckx S; Carai P; Verhesen W; Eelen G; Schoors S; van Leeuwen R; Alekseev S; Elzenaar I; Vinckier S; Pokreisz P; Walravens AS; Gijsbers R; Van Den Haute C; Nickel A; Schroen B; van Bilsen M; Janssens S; Maack C; Pinto Y; Carmeliet P; Heymans S
    Circulation; 2017 Aug; 136(8):747-761. PubMed ID: 28611091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy.
    Huang S; Zou X; Zhu JN; Fu YH; Lin QX; Liang YY; Deng CY; Kuang SJ; Zhang MZ; Liao YL; Zheng XL; Yu XY; Shan ZX
    J Cell Mol Med; 2015 Mar; 19(3):608-19. PubMed ID: 25583328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol Ameliorates Cardiac Hypertrophy by Down-regulation of miR-155 Through Activation of Breast Cancer Type 1 Susceptibility Protein.
    Fan Y; Liu L; Fang K; Huang T; Wan L; Liu Y; Zhang S; Yan D; Li G; Gao Y; Lv Y; Chen Y; Tu Y
    J Am Heart Assoc; 2016 Apr; 5(4):. PubMed ID: 27107135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of microRNA-22 derepressed PTEN to effectively protect rat cardiomyocytes from hypertrophy.
    Xu XD; Song XW; Li Q; Wang GK; Jing Q; Qin YW
    J Cell Physiol; 2012 Apr; 227(4):1391-8. PubMed ID: 21618527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489.
    Wang K; Liu F; Zhou LY; Long B; Yuan SM; Wang Y; Liu CY; Sun T; Zhang XJ; Li PF
    Circ Res; 2014 Apr; 114(9):1377-88. PubMed ID: 24557880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.
    Yu XJ; Huang YQ; Shan ZX; Zhu JN; Hu ZQ; Huang L; Feng YQ; Geng QS
    Life Sci; 2019 Sep; 232():116635. PubMed ID: 31283925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.
    Liu L; An X; Li Z; Song Y; Li L; Zuo S; Liu N; Yang G; Wang H; Cheng X; Zhang Y; Yang X; Wang J
    Cardiovasc Res; 2016 Jul; 111(1):56-65. PubMed ID: 27084844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of microRNA-1 derepresses the cytoskeleton regulatory protein twinfilin-1 to provoke cardiac hypertrophy.
    Li Q; Song XW; Zou J; Wang GK; Kremneva E; Li XQ; Zhu N; Sun T; Lappalainen P; Yuan WJ; Qin YW; Jing Q
    J Cell Sci; 2010 Jul; 123(Pt 14):2444-52. PubMed ID: 20571053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-150 Protects Against Pressure Overload-Induced Cardiac Hypertrophy.
    Liu W; Liu Y; Zhang Y; Zhu X; Zhang R; Guan L; Tang Q; Jiang H; Huang C; Huang H
    J Cell Biochem; 2015 Oct; 116(10):2166-76. PubMed ID: 25639779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-222 inhibits pathological cardiac hypertrophy and heart failure.
    Liu X; Li H; Hastings MH; Xiao C; Damilano F; Platt C; Lerchenmüller C; Zhu H; Wei XP; Yeri A; Most P; Rosenzweig A
    Cardiovasc Res; 2024 Mar; 120(3):262-272. PubMed ID: 38084908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.